Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-28

Clinical Trial Update: Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients? [NA]

View source ↗

Summary

A clinical trial update examining whether vitamin D supplementation improves sustained virologic response in genotype 2 and 3 chronic hepatitis C patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Ziv Hospital | Conditions: Hepatitis C | NA | Status: UNKNOWN